Bactericidal activity of nukacin ISK-1: an alternative mode of action

References

• Cotter PD, Ross RP, Hill C. Bacteriocins- a viable alternative to antibiotics? Nat. Rev. Microbiol. 2013;11:95–105.
   PubMed Web of Science ®Google Scholar
• Delves-Broughton J, Blackburn P, Evans RJ, Hugenholtz J. Applications of the bacteriocin, nisin. Antonie van Leeuwenhoek. 1996;69:193–202.10.1007/BF00399424
   PubMed Web of Science ®Google Scholar
• Joo NE, Ritchie K, Kamarajan P, Miao D, Kapila YL. Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1. Cancer Med. 2012;1:295–305.10.1002/cam4.35
   PubMed Web of Science ®Google Scholar
• Jung G. Lantibiotics: a survey. In: Jung G, Sahl H-G, editors. Nisin and novel lantibiotics. Leiden: ESCOM; 1991. p. 1–34.
   Google Scholar
• Willey JM, van der Donk WA. Lantibiotics: peptides of diverse structure and function. Annu. Rev. Microbiol. 2007;61:477–501.10.1146/annurev.micro.61.080706.093501
   PubMed Web of Science ®Google Scholar
• Wiedemann I, Benz R, Sahl H-G. Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane study. J. Bacteriol. 2004;186:3259–3261.10.1128/JB.186.10.3259-3261.2004
   PubMed Web of Science ®Google Scholar
• Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, Bulaj G, Camarero JA, Campopiano DJ, Challis GL, Clardy J, Cotter PD, Craik DJ, Dawson M, Dittmann E, Donadio S, Dorrestein PC, Entian KD, Fischbach MA, Garavelli JS, Göransson U, Gruber CW, Haft DH, Hemscheidt TK, Hertweck C, Hill C, Horswill AR, Jaspars M, Kelly WL, Klinman JP, Kuipers OP, Link AJ, Liu W, Marahiel MA, Mitchell DA, Moll GN, Moore BS, Müller R, Nair SK, Nes IF, Norris GE, Olivera BM, Onaka H, Patchett ML, Piel J, Reaney MJ, Rebuffat S, Ross RP, Sahl HG, Schmidt EW, Selsted ME, Severinov K, Shen B, Sivonen K, Smith L, Stein T, Süssmuth RD, Tagg JR, Tang GL, Truman AW, Vederas JC, Walsh CT, Walton JD, Wenzel SC, Willey JM, van der Donk WA. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat. Prod. Rep. 2013;30:108–160.10.1039/c2np20085f
   PubMed Web of Science ®Google Scholar
• Islam MR, Nishie M, Nagao J, Zendo T, Keller S, Nakayama J, Kohda D, Sahl H-G, Sonomoto K. Ring A of nukacin ISK-1: a lipid II-binding motif for type-A(II) lantibiotic. J. Am. Chem. Soc. 2012;134:3687–3690.10.1021/ja300007h
   PubMed Web of Science ®Google Scholar
• Asaduzzaman SM, Nagao J, Iida H, Zendo T, Nakayama J, Sonomoto K. Nukacin ISK-1, a bacteriostatic lantibiotic. Antimicrob. Agents Chemother. 2009;53:3595–3598.10.1128/AAC.01623-08
   PubMed Web of Science ®Google Scholar
• Aso Y, Okuda K, Nagao J, Kamenasa Y, Phuong NTB, Koga H, Shioya K, Sashihara T, Nakayama J, Sonomoto K. A novel type of immunity protein, NukH, for the lantibiotic nukacin ISK-1 produced by Staphylococcus warneri ISK-1. Biosci. Biotechnol. Biochem. 2005;69:1403–1410.10.1271/bbb.69.1403
   PubMed Web of Science ®Google Scholar
• Bonelli RR, Schneider T, Sahl H-G, Wiedemann I. Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies. Antimicrob. Agents Chemother. 2006;50:1449–1457.10.1128/AAC.50.4.1449-1457.2006
   PubMed Web of Science ®Google Scholar
• Silverman JA, Perlmutter NG, Shapiro HM. Correction of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob. Agents Chemother. 2003;47:2538–2544.10.1128/AAC.47.8.2538-2544.2003
   PubMed Web of Science ®Google Scholar
• Jack R, Benz R, Tagg J, Sahl H-G. The mode of action of SA-FF22, a lantibiotic isolated from Streptococcus pyogenes strain FF22. Eur. J. Biochem. 1994;219:699–705.10.1111/ejb.1994.219.issue-1-2
   PubMedGoogle Scholar
• Herranz C, Cintas LM, Hernandez PE, Moll GN, Driessen AJM. Enterocin P causes potassium ion efflux from Enterococcus faecium T136 cells. Antimicrob. Agents Chemother. 2001;45:901–904.10.1128/AAC.45.3.901-904.2001
   PubMed Web of Science ®Google Scholar
• Mantovani HC, Russel JB. Bovicin HC5, a lantibiotic produced by Streptococcus bovis HC5, catalyzes the efflux of intracellular potassium but not ATP. Antimicrob. Agents Chemother. 2008;52:2247–2249.10.1128/AAC.00109-08
   PubMed Web of Science ®Google Scholar
• Iida H, Wang L, Nishii K, Ookuma A, Shibata Y. Identification of rab12 as a secretory granule-associated small GTP-binding protein in atrial myocytes. Circ. Res. 1996;78:343–347.10.1161/01.RES.78.2.343
   PubMed Web of Science ®Google Scholar
• Christ K, Al-Kaddah S, Wiedemann I, Rattay B, Sahl H-G, Bendas G. Membrance lipids determine the antibiotic activity of the lantibiotic gallidermin. J. Membr. Biol. 2008;226:9–16.10.1007/s00232-008-9134-4
   PubMed Web of Science ®Google Scholar